Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The extended half-life results from reduced renal clearance, as the unbound peptide avoids the protective complexes that normally prevent glomerular filtration
What to monitor Track the following metrics to assess whether the levocarnitine addition is providing value: Body composition changes (use DEXA, InBody, or similar if accessible) Energy levels and exercise performance GI symptoms (compare to baseline on tirzepatide alone if possible) Liver function markers (ALT, AST) if baseline values were elevated General well-being and recovery quality If after 8 to 12 weeks the levocarnitine addition has not produced noticeable improvements in energy, exercise performance, or body composition compared to tirzepatide alone, consider adjusting your protocol or switching to a different compound blend
The syringe visuals above will update in real-time.
Sourcing matters: always look for third-party testing and a Certificate of Analysis
